Headline
The latest stories from AHA Today.
SCA Pharmaceuticals has recalled 10 lots of compounded heparin sodium, an anticoagulant packaged in 500 mL or 1000 mL intravenous bags, the Food and Drug Administration announced.
The Centers for Medicare & Medicaid Services yesterday published guidance for states on the treatment of third party payers in determining the hospital-specific Medicaid disproportionate share hospital payment limits for the state plan rate year 2017 DSH audits.
The AHA urged the Office of Management and Budget to expedite its review and release of final regulations on physician self-referral and the Anti-Kickback Statute that were submitted in July by the Centers for Medicare & Medicaid Services and the Department of Health & Human Services Office…
The Centers for Disease Control and Prevention released a study examining how COVID-19 is affecting American Indians and Alaska Natives — one of the populations at highest risk for the disease.
The Department of Health and Human Services amended the declaration under the Public Readiness and Emergency Preparedness Act to authorize state-licensed pharmacists and pharmacy interns under their supervision to order and administer vaccines to children, subject to certain requirements.
The Food and Drug Administration released a resource to help U.S. health care providers select respirators for their health care facility.
The National Institute for Occupational Safety and Health released a report summarizing the particulate filtration efficiency of non-NIOSH-approved N95 respirators made in other countries and authorized for emergency use during the COVID-19 public health emergency.
The AHA urged President Trump and the Department of Health and Human Services to continue to act on behalf of hospitals and health systems by further expanding telehealth flexibilities.
The AHA unveiled the latest component of the association’s Wear A Mask initiative, with new content and collaborations to share resources and amplify key public health messages to stop the spread of COVID-19.
At Dell Seton Medical Center, clinicians observed that patients with opioid use disorder had a high likelihood of readmission because its underlying causes were not being addressed.